Clene (NASDAQ: CLNN) , a late clinical-stage biopharma company developing treatments for neurodegenerative diseases, reported Q2 2025 results and sai ...

Four volunteers with paralysis manage to communicate thanks to a brain reader that only activates when they think of the ...

In that moment, things clicked. A year ago, my father died after an absolutely brutal battle with amyotrophic lateral ...

By decoding neural signals linked to a person’s inner monologue, researchers enabled communication for individuals with ...

A brain-computer interface has enabled people with paralysis to turn their thoughts about speech into played out words, ...

In a recent study, scientists successfully decoded not only the words people tried to say but the words they merely imagined saying.

Uruguay's Chamber of Deputies, the lower house of Parliament, approved a bill on so-called "death with dignity" that would ...

The Company plans to hold an end-of-Phase 2 Type B meeting with the FDA in the third quarter of 2025. This meeting will review results from the Phase 2 VISIONARY-MS trial and discuss the planned Phase ...

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, announced today ...

Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to ...

From in-home help to nursing homes and everything in between, there is a wide range of care options for older adults in ...